Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer - United States
doi 10.1002/cncr.30683
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

BCL11A Confers Cell Invasion and Migration in Androgen Receptor‑positive Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Expression of Androgen Receptor and C-Kit (CD117) in Triple Negative Breast Cancer

Immunopathology, Allergology, Infectology
2016English

Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison

Human Pathology
Forensic MedicinePathology
2016English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Triple-Negative Breast Cancer

2018English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Prohibitin Promotes Androgen Receptor Activation in ER-positive Breast Cancer

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy